C4 Therapeutics (CCCC) Change in Account Payables (2019 - 2025)
Historic Change in Account Payables for C4 Therapeutics (CCCC) over the last 7 years, with Q3 2025 value amounting to -$885000.0.
- C4 Therapeutics' Change in Account Payables fell 25000.0% to -$885000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$641000.0, marking a year-over-year decrease of 36820.08%. This contributed to the annual value of -$119000.0 for FY2024, which is 14358.97% down from last year.
- Per C4 Therapeutics' latest filing, its Change in Account Payables stood at -$885000.0 for Q3 2025, which was down 25000.0% from $1.5 million recorded in Q2 2025.
- C4 Therapeutics' Change in Account Payables' 5-year high stood at $1.5 million during Q2 2025, with a 5-year trough of -$2.0 million in Q1 2021.
- Over the past 5 years, C4 Therapeutics' median Change in Account Payables value was -$176000.0 (recorded in 2024), while the average stood at -$229157.9.
- Examining YoY changes over the last 5 years, C4 Therapeutics' Change in Account Payables showed a top increase of 31454.55% in 2025 and a maximum decrease of 45439.56% in 2025.
- C4 Therapeutics' Change in Account Payables (Quarter) stood at $760000.0 in 2021, then crashed by 241.58% to -$1.1 million in 2022, then soared by 115.71% to $169000.0 in 2023, then tumbled by 204.14% to -$176000.0 in 2024, then tumbled by 402.84% to -$885000.0 in 2025.
- Its last three reported values are -$885000.0 in Q3 2025, $1.5 million for Q2 2025, and -$645000.0 during Q1 2025.